Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Big cannabis stocks are rallying on Monday, with many posting double-digits gains.
So what’s going on?
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Alan Brochstein, author of the 420 Investor and founder of New Cannabis Ventures, said the move "seems driven by Canadian LPs, and some of that may be short-covering."
If what we're seeing is short covering, he said the move is broad and spans across the market, as volumes are showing considerable upticks.
"I would note that small-caps in the U.S. are breaking to recent highs, and perhaps there is in general a stronger appetite for risk by investors," Brochstein told Benzinga.
Among the top gainers at time of writing:
- Greenlane Holdings Inc (NASDAQ:GNLN) up 23%
- Acreage Holdings Inc (OTC:ACRGF) up 19%
- Medmen Enterprises Inc (OTC:MMNFF) up 12.8%
- Tilray Inc (NASDAQ:TLRY) up 12.4%
- Canopy Growth (NYSE:CGC) up 10%
- Hexo Corp (NYSE:HEXO) up 10.9%
- Aphria Inc (NYSE:APHA) up 8.2%
- Cronos Group Inc (NASDAQ:CRON) up 6.7%
- Curaleaf Holdings Inc (OTC:CURLF) up 6.7%
- Aurora Cannabis Inc (NYSE:ACB) up 6%
Short-Covering
Matt Markiewicz, Managing Director of Innovation Shares, currently in charge of the firm’s cannabis ETF, seems to agree with Brochstein: short-covering looks like the main driver behind the rally right now.
“With no fundamental news driving the space today, it smells like a classic short-cover rally especially in the blue chip LPs,” he told Benzinga.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
To illustrate his point, Markiewicz brought up one of the most popular cannabis shorts: Tilray. The stock has 22% of its float short right now; this is pretty high compared to other Canadian LPs such as Canopy, at 18%, and Organigram at 8%.
“With nearly 17 million shares short right now, Tilray’s short interest is up over 50% in a month. These types of sharp moves, like we've seen in the first half hour today, have really forced short sellers’ hands early in the trading session,” he explained.
“On the whole though, there is a general bid for risk and small cap equities in the market today and cannabis leveraged names are along for the ride.”
This price action is also giving a boost to cannabis ETFs:
- The ETFMG Alternative Harvest ETF (NYSE:MJ) up 4.75%.
- The AdvisorShares Pure Cannabis ETF (NYSE:YOLO) up 4.74%.
- The Cannabis ETF (NYSE:THCX) up 5.38%.
- The Amplify Seymour Cannabis ETF (NYSE:CNBS) up 5.44%.
'No Good Reason'
Unlike his peers above, Dan Ahrens, a Managing Director and the Chief Operating Officer of AdvisorShares, thinks "there's no good reason a stock like Tilray or HEXO or Cronos should be up like this."
On the other hand, he noted a stock like Trulieve (OTC:TCNNF) "should be way up with Florida setting record sales. But not Tilray or HEXO.
"I think it's at least miss-placed optimism. Maybe even an actual short squeeze. People reading about dispensaries being essential, and big sales increases, then buying up just the known, heavily-traded cannabis names like Tilray," he concluded.
Lead image by Ilona Szentivanyi. Copyright: Benzinga.
Versión en Español en El Planteo: Por qué Están Subiendo las Acciones de Cannabis Hoy: Tilray, Canopy Growth, Aurora, Curaleaf y Más
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.